North Texas health officials said they are keeping a close eye on the spread in outbreak communities and have plans in place ...

Werewolf Therapeutics provided a business update, announcing progress in their clinical trials for WTX-124, a conditionally activated therapeutic for cutaneous melanoma, with full enrollment in ...

Reports Q4 revenue $0 vs. $301,590. “Werewolf made considerable progress in 2024 with promising preliminary evidence of durable anti-tumor ...

Sunday looks to be the beginning of a warming trend in West Central Texas. St. Patrick's Day Monday we look to have highs in ...

- Full enrollment in cutaneous melanoma dose-expansion arms of Phase 1/1b clinical trial evaluating WTX-124 as monotherapy ...

The Midland Chamber of Commerce hosted their 4th Annual WTX Women’s Symposium. The event is designed to empower women in ...

With the ability to detect and quantify over 18,000 RNA transcripts at single-cell and subcellular resolution, the WTX assay enables comprehensive spatial transcriptomics. The intricate molecular ...

Full enrollment in cutaneous melanoma dose-expansion arms of Phase 1/1b clinical trial evaluating WTX-124 as monotherapy and in combination with pembrolizumab expected by the end of the first half and ...